Stanelco PLC
01 May 2008
Stanelco PLC ('Stanelco' or the 'Company')
Directors' Dealing
Stanelco has today granted options to the trustees of the Stanelco Plc Employee
Benefit Trust (the 'EBT') to acquire (by way of subscription) 88,100,000
ordinary shares of 0.1p each in the capital of the Company ('Ordinary Shares')
at an exercise price of 0.8 pence per Ordinary Share (the 'Options').
The Company's Executive Directors and Persons Discharging Managerial
Responsibility ('PDMR') are potentially interested in the Options.
In accordance with the Share Options Policy adopted by the Remuneration
Committee the Options are issued with the following performance conditions:
On the expiration of 3 years from date of grant of the Options, if the Company's
share price is equal to 1p then 25 per cent. of the Options will become
available for exercise. The proportion of Options available for exercise will
increase pro rata up to 100 per cent. if the Company's share price is 2.5p or
greater.
Stanelco intends, in due course, to issue a letter of wishes in respect of the
Options to the trustees of the EBT asking them to consider appointing the
Options to sub trusts for the benefit of Mr Paul Mines, his spouse, widow,
children or stepchildren under the age of 18 years old (in respect of an option
over 37,500,000 Ordinary Shares) and for the benefit of Mr Clive Warner, his
spouse, widow, children or stepchildren under the age of 18 years old (in
respect of an option over 30,000,000 Ordinary Shares) and for the benefit of Mr
Paul Law, his spouse, widow, children or stepchildren under the age of 18 years
old (in respect of an option over 20,600,000 Ordinary Shares) each of which are
at an exercise price of 0.8 pence per Ordinary Share, lapsing 27 April 2018,
representing an award equal to 200 per cent. of salary in accordance with the
Share Options Policy.
The appointment of these Options into the proposed sub-trusts is at the
discretion of the trustees of the EBT and a further announcement will be made by
the Company should they choose to act on the letter of wishes.
Following the granting of the Options to the EBT, the Company's Directors and
PDMRs are interested in the following options over Ordinary Shares:
Date Granted Date Date option Exercise Ordinary
exercisable lapses price Shares
Stanelco PLC 2005 Unapproved Share
option Plan and Stanelco PLC Employment
Benefit Trust
The following options over Ordinary 28 April 2008 28 April 2011 27 April 2018 0.8p 88,100,000
Shares are held by the Trustees of the
Stanelco PLC Employee Benefit Trust for
the benefit of all Directors and
employees
The following options over Ordinary
Shares have been appointed to sub
trusts for the benefit of the following
Directors and their families
Paul Mines 4 July 2007 4 July 2010 3 July 2017 0.52p 57,692,308
Clive Warner 4 July 2007 4 July 2010 3 July 2017 0.52p 46,153,846
13 March 2006 13 March 2009 12 March 2016 15.18p 5,000,000
- Ends -
For further information please contact:
Jonathon Brill/Billy Clegg
Financial Dynamics
Tel: +44 (0)20 7831 3113
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.